𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Temporally controlled somatic mutagenesis in smooth muscle

✍ Scribed by Susanne Kühbandner; Sabine Brummer; Daniel Metzger; Pierre Chambon; Franz Hofmann; Robert Feil


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
417 KB
Volume
28
Category
Article
ISSN
1526-954X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Temporally controlled targeted somatic m
✍ Michael Schuler; Faisal Ali; Elisabeth Metzger; Pierre Chambon; Daniel Metzger 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 604 KB

To generate temporally controlled targeted somatic mutations selectively and efficiently in skeletal muscles, we established a transgenic HSA-Cre-ER(T2) mouse line in which the expression of the tamoxifen-dependent Cre-ER(T2) recombinase is under the control of a large genomic DNA segment of the hum

Efficient temporally controlled targeted
✍ Michael Schuler; Andrée Dierich; Pierre Chambon; Daniel Metzger 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB

## Abstract To generate temporally controlled targeted somatic mutations selectively and efficiently in hepatocytes, we established SA^+/CreERT2^ mice in which the tamoxifen‐dependent Cre‐ER^T2^ recombinase coding sequence preceded by an internal ribosomal entry site was inserted in the 3′ untransl

High-efficiency somatic mutagenesis in s
✍ John J. Lepore; Lan Cheng; Min Min Lu; Patricia A. Mericko; Edward E. Morrisey; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB

The cytoskeletal protein SM22alpha is expressed in visceral and vascular smooth muscle cells (SMCs), in cardiac myocytes, and in the myotomal components of the somites during murine embryonic development. In this report, we describe the generation and characterization of transgenic mice expressing C

Magnesium used in bioabsorbable stents c
✍ Katrin Sternberg; Matthias Gratz; Kathleen Koeck; Joerg Mostertz; Robert Begunk; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 839 KB

## Abstract Magnesium‐based bioabsorbable cardiovascular stents have been developed to overcome limitations of permanent metallic stents, such as late stent thrombosis. During stent degradation, endothelial and smooth muscle cells will be exposed to locally high magnesium concentrations with yet un